期刊文献+

澳洲茄边碱对前列腺癌细胞增殖的抑制作用及机制研究 被引量:4

Effect and mechanism of solamargine on proliferation of prostate cancer cells
下载PDF
导出
摘要 目的研究澳洲茄边碱(solamargine,SM)对人前列腺癌激素非依赖细胞增殖的影响及可能的作用机制。方法用不同浓度SM(0、1、2、4、6、8、10μmol/L)处理DU145和PC3细胞,MTT法检测SM对细胞生长的影响,Western blot检测SM对相关信号通路蛋白p38 MAPK、ERK1/2 MAPK、MUC1表达的影响。结果 6μmol/L SM作用24h后DU145和PC3细胞活力分别为(52.53±9.05)%、(56.28±2.36)%,并具有时间和剂量依赖;10μmol/L SM作用24h后细胞活力分别为(27.36±2.72)%、(32.07±2.53)%。流式细胞术分析显示不同浓度SM(0、4、6、8μmol/L)处理PC3细胞能引起PC3细胞阻滞在G1期,G1期细胞比例分别为(52.61±0.50)%、(52.96±1.49)%、(66.16±2.84)%和(69.03±2.38)%。且能激活MAPK信号通路减少下游蛋白MUC1的表达。结论 SM能明显抑制DU145和PC3细胞生长,该作用可能与MAPK信号通路的激活以及下游MUC1蛋白表达下调有关。 Objective To investigate the effect of solamargine (SM)on the proliferation of prostate cancer cells and the possible mechanism. Methods DU145 and PC3 cells were treated with different concentration of SM (0,1,2,4,6,8,10μmol/L). MTT assay were used to detect the inhibiting effect of SM on the proliferation of DU145 and PC3. Expression of p38 MAPK, ERK1/2 MAPK,MUC1 protein were detected by Western blot. Cell cycle was detected by flow cy-tometry. Results The cell viability of DU145 and PC3 cells after treated with 6μmol/L SM for 24 h were (52.53±9.05)% and (56.28±2.36)%. With time and dose dependent,when treated with 10μmol/L SM for 24 h were (27.36±2.72)%,(32.07±2.53)%. SM (0,4,6,8μmol/L) can induce cell cycle arrest at G0/G1 phase of PC3 and activate MAPK signal pathway which can re-duce the downstream protein MUC1 expression. The cell rate of G1 were (52.61±0.50)%,(52.96± 1.49)%,(66.16±2.84)% and (69.03±2.38)%,respectively. Conclusions SM can inhibit the growth of DU145 and PC3. The mechanism may be related to the activation of MAPK signal path-way and cut on the downstream MUC1 protein expression.
出处 《现代泌尿生殖肿瘤杂志》 2016年第1期36-40,共5页 Journal of Contemporary Urologic and Reproductive Oncology
关键词 前列腺癌 细胞增殖 MUC1 澳洲茄边碱 Prostate cancer Cell proliferation MAPK MUC1 Solamargine
  • 相关文献

参考文献11

  • 1Liang CH. Shiu L Y. Chang LC. et al. Solamargine upregula?tion of Fas , downregulation of HER2. and enhancement of cytotoxicity using epirubicin in NSCLC cells[J]. Mol Nutr Food Res.2007 .51<S) :999-1005.
  • 2Zhou Y. Tang Q. Zhao S. et al. Targeting signal transducer and activator of transcription 3 contributes to the solamargine?inhibited growth and -induced apoptosis of human lung cancer cells[]]. Tumour Biol , 2014.35 (8) : 8169-8178.
  • 3Bashir MN. Epidemiology of Prostate Cancer[J]. Asian PacJ Cancer Prev.201S.16(13) :S137-5141.
  • 4Liu LF. Liang CH. Shiu L Y. et al. Action of sola margine on human lung cancer cells-enhancement of the susceptibility of cancer cells to TNFs[]]' FEBS Lett.2004.577(]-2) :67-74.
  • 5Liang CH. Shiu LY. Chang LC, et al. Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin[J]. Chern Res Toxico1,200S,21(2) :393-399.
  • 6Sun L. Zhao v . Li X. et al. A lysosomal-mitochondrial death pathway is induced by solamargine in human K562 leukemia cells[J]. Toxicol In Vitro.2010,24(6): 1504-1511.
  • 7Qi M, Elion EA. MAP kinase pathways[J].J Cell Sci.2005. l1S(Pt 16): 3569-3572.
  • 8Deschenes-Simard X. Kottakis F, Meloche S. et al. ERKs in cancer: friends or foes?[J]. Cancer Res, 2014.74 (2): 412- 419.
  • 9O'ConnorJC,JulianJ, Lim SO. et al. MUC1 expression in human prostate cancer cell lines and primary tumors[J]. Prostate Cancer Prostatic Dis,200S.S0) :36-44.
  • 10李静,周建甫,张秋红,汪茜,韩守威,陈志强,向松涛.RNA干扰沉默MUC1-C对前列腺癌PC3细胞增殖的影响[J].现代泌尿生殖肿瘤杂志,2014,6(6):356-358. 被引量:1

二级参考文献12

  • 1Kufe DW. Mucins in cancer: function, prognosis and therapy [J]. Nat Rev Cancer,2009,9(12) :874-885.
  • 2Kufe DW. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches [J]. Oncogene,2013,32(9) :1073-1081.
  • 3Xiang ST, Zhou SW, Guan W, et al. Tumor infiltrating den- dritic cells and mucinl gene expression in benign prostatic hy- perplasia and prostate cancer[J]. Zhonghua Nan Ke Xue, 2003,9(7) :497-500.
  • 4Rabiau N, Dechelotte P, Guy L, et al. Immunohistochemical staining of mucin 1 in prostate tissues[J]. In Vivo, 2009,23 (2) :203-207.
  • 5Siegel R, Ma J, Zou Z, et al. Cancer statistics,2014[J]. CA Cancer J Clin,2014,64(1) :9-29.
  • 6Huang L, Chen D, Liu D, et al. MUC1 oncoprntein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin[J]. Cancer Res, 2005,65 (22) 10413-10422.
  • 7A_gata N, Ahmad R, Kawano T, et al. MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8[J]. Cancer Res,2008,68(15):6136-6144.
  • 8Kharbanda A, Rajabi H, Jin C, et al. Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer[J]. Mol Cancer Res,2013,11(7):714-723.
  • 9Parrondo R, de las Pozas A, Reiner T, et al. NF-kappaB ac- tivation enhances cell death by antimitotic drugs in human prostate cancer cells[J]. Mol Cancer, 2010,9 : 182.
  • 10Gaur RK. RNA interference: a potential therapeutic tool for silencing splice isoforms linked to human diseases[J]. Bio- techniques, 2006, Suppl : 15-22.

同被引文献38

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部